Tracing the Footsteps of Mountains, Waters, and Sages While Exploring New Growth Opportunities in the Pharmaceutical Industry — Industry Leaders Gather in the “Spring City,” as Keyyuan Pharmaceutical’s Subsidiary Unveils Several Major New Products
Publish Time:
2026-04-27
From April 24 to 27, the themed event “Tracing the Footsteps of a Mountain, a River, and a Sage; Exploring the Origins of Gold, an Award, and a Renowned Hall” was successfully held in Jinan. This event not only marked the official kickoff of the 2026 work conference of the Retail Pharmacy Branch and the Independent Pharmacy Branch of the China Association for Medical Supplies, but also formally inaugurated the “Climbing Mount Tai, Paying Respects at the Confucius Temple, Embarking on a New Journey—Hongjitang Pharmaceutical & Dengsheng Pharmaceutical’s Traditional Chinese Culture Tour: Joint Exploration of Non-Pharmaceutical Revenue Growth” series of activities.
From April 24 to 27, the themed event “Tracing the Footsteps of One Mountain, One Waterbody, and One Sage; Revisiting One Gold Award, One Prestigious Prize, and One Time-Honored Brand” was successfully held in Jinan. This event not only marked the official kickoff of the 2026 Work Conference of the Retail Pharmacy Branch and the Independent Pharmacy Branch of the China Association of Pharmaceutical Materials, but also formally inaugurated the “Climbing Mount Tai, Paying Respects at the Confucius Temple, Embarking on a New Journey—Hongjitang Pharmaceutical & Dengsheng Pharmaceutical’s Traditional Chinese Culture Tour: Joint Exploration of Non-Pharmaceutical Revenue Growth” series of activities. Hundreds of representatives from the China Association of Pharmaceutical Materials, the Retail Pharmacy Branch, the Independent Pharmacy Branch, and pharmaceutical chain enterprises across the country gathered in the Qilu region to discuss industry development, explore opportunities for market growth, and embark on a new journey of integrating culture with industry.

During the four-day visit to Shandong, the attendees made a special trip to the Digital and Intelligent Injection Factory of Shandong Linuo Pharmaceutical, a subsidiary of Shandong Keyuan Pharmaceutical Co.,Ltd. (stock code: 301281.SZ), for an inspection and study tour. As an intelligent factory in Jinan City for 2026 and a green, low-carbon, high-quality development project in Shandong Province, the Linuo Pharmaceutical Injection Digital and Intelligent Factory has leveraged cutting-edge technologies such as digital twins, 5G, AI visual inspection, and AGV smart logistics to build a modern production benchmark that integrates automated manufacturing, intelligent control, and end-to-end traceability. The guests visited the lyophilized powder for injection and BFS intelligent production lines, observing firsthand the entire process—from raw material handling and precise filling and aseptic production to intelligent light inspection and logistics distribution—and highly commended the factory’s level of intelligent manufacturing, its quality control system, and its commitment to green production.

At the networking gala, Linuo Pharmaceutical unveiled several of its flagship new products, including Diphenhydramine Hydrochloride Tablets, Betahistine Hydrochloride Tablets, Ferrous Succinate Oral Solution, Minoxidil Topical Solution, and Ambroxol Hydrochloride Drops, as well as its well-established household staple brands such as Isosorbide Dinitrate Spray and Ammonium Salicylate Paste. These offerings span critical clinical areas—including cardiovascular and cerebrovascular health, allergy relief, vertigo management, iron supplementation, hair growth, respiratory care, and oral health—thereby comprehensively enriching the product portfolio available at retail pharmacies.

As a wholly owned subsidiary of the listed company Keyuan Pharmaceutical, the company has been deeply engaged in the chronic disease pharmaceutical sector for more than two decades. Leveraging its integrated API–formulation capabilities, end-to-end digital and intelligent manufacturing processes, and comprehensive quality control across the entire supply chain, it continuously develops high-quality, premium medicines. The products unveiled this time are precisely tailored to meet the needs of retail pharmacies for medications used to treat common and chronic conditions as well as for household essential medicines. Moving forward, the company will collaborate with partners nationwide to provide consumers with higher-quality, more convenient medication options and jointly tap into the incremental growth opportunities in the pharmaceutical retail market.

This event has not only established a high-quality platform for exchange and collaboration within the pharmaceutical industry, but also underscored the robust strengths of Shandong’s pharmaceutical sector in intelligent manufacturing, brand leadership, and cultural empowerment. Moving forward, Keyuan Pharmaceutical and Linuo Pharmaceutical will continue to work closely with the China Association of Pharmaceutical Materials and pharmaceutical chain partners nationwide, taking culture as the soul, quality as the foundation, and innovation as the driving force, to deepen their presence in the pharmaceutical retail market, expand non-pharmaceutical growth opportunities, jointly promote high-quality industry development, and safeguard public health.
Latest News